https://news.medxy.ai/zh/63955-2/Medxy AIzh2026-08-16T09:17:27-07:00 https://news.medxy.ai/ja/63954-2/Medxy AIja2026-08-16T09:17:09-07:00 https://news.medxy.ai/vi/63953-2/Medxy AIvi2026-08-16T09:16:51-07:00 https://news.medxy.ai/ja/organ-transplant-guidelines/Medxy AIja2026-08-16T09:13:31-07:00逐次的移植研究に新指針：臓器レベル試験を安全かつ効率的に進めるためのコンセンサスガイドライン https://news.medxy.ai/vi/sequential-transplantation-guidelines/Medxy AIvi2026-08-16T09:12:56-07:00Nghiên cứu ghép tạng tuần tự: Hướng dẫn đồng thuận mới về thử nghiệm an toàn, hiệu quả ở cấp cơ quan https://news.medxy.ai/zh/sequential-transplant-guidelines/Medxy AIzh2026-08-16T09:12:28-07:00序贯移植研究：关于安全高效开展器官级试验的最新共识指南 https://news.medxy.ai/zh/mild-tbi-sleep-emotion/Medxy AIzh2026-08-16T09:05:08-07:00慢性轻度创伤性脑损伤患者睡眠与情绪症状的特征：一项综合综述 https://news.medxy.ai/ja/chronic-mtbi-symptoms/Medxy AIja2026-08-16T09:04:48-07:00慢性mTBIにおける患者報告の睡眠・気分症状を読み解く：包括的レビュー https://news.medxy.ai/vi/sleep-mood-characteristics/Medxy AIvi2026-08-16T09:04:22-07:00Đặc điểm triệu chứng giấc ngủ và khí sắc do bệnh nhân tự báo cáo trong chấn thương sọ não nhẹ mạn tính: Tổng quan toàn diện https://news.medxy.ai/zh/lean-nonalcoholic-fatty-liver-disease/Medxy AIzh2026-08-16T08:50:27-07:00隐源性脂肪性肝病：与肝相关死亡风险升高相关的瘦型表型解析 https://news.medxy.ai/ja/cryptogenic-steatotic-liver-disease/Medxy AIja2026-08-16T08:50:09-07:00Cryptogenic Steatotic Liver Disease：肝関連死亡リスクを高める痩身型表現型の解明 https://news.medxy.ai/vi/lean-fatty-liver-disease/Medxy AIvi2026-08-16T08:49:47-07:00Bệnh gan nhiễm mỡ hóa vô căn: Nhận diện kiểu hình thể gầy liên quan đến tử vong do gan tăng cao https://news.medxy.ai/ja/flt3-itd-mrd-testing/Medxy AIja2026-08-16T08:47:05-07:00急性骨髄性白血病におけるNGSベースFLT3-ITD MRD検査：ELN-DAVID推奨の実践ガイド https://news.medxy.ai/structure-of-the-genetic-risks-for-psychiatric-disorders-in-swedish-population-based-registries/Medxy AIen2026-08-15T18:57:06-07:00Structure of the Genetic Risks for Psychiatric Disorders in Swedish Population-Based Registries https://news.medxy.ai/psychoactive-medication-prescribing-after-critical-illness-in-american-adults-not-justified-by-a-documented-supporting-diagnosis/Medxy AIen2026-08-15T18:55:50-07:00Psychoactive Medication Prescribing After Critical Illness in American Adults Not Justified by a Documented Supporting Diagnosis https://news.medxy.ai/enhancing-internal-medicine-resident-competency-in-diabetes-care-comparing-experience-based-and-traditional-continuous-glucose-monitoring-curricula/Medxy AIen2026-08-15T18:54:28-07:00Enhancing Internal Medicine Resident Competency in Diabetes Care: Comparing Experience-Based and Traditional Continuous Glucose Monitoring Curricula https://news.medxy.ai/medicare-advantage-and-type-2-diabetes-outcomes-evaluating-clinical-and-social-impacts-amid-rising-costs/Medxy AIen2026-08-15T18:52:40-07:00Medicare Advantage and Type 2 Diabetes Outcomes: Evaluating Clinical and Social Impacts Amid Rising Costs https://news.medxy.ai/comparative-safety-and-efficacy-of-team-versus-beam-conditioning-regimens-in-autologous-transplantation-for-lymphoma-a-comprehensive-review/Medxy AIen2026-08-15T18:50:39-07:00Comparative Safety and Efficacy of TEAM versus BEAM Conditioning Regimens in Autologous Transplantation for Lymphoma: A Comprehensive Review https://news.medxy.ai/meconium-aspiration-syndrome-and-its-association-with-preschool-asthma-a-comprehensive-review/Medxy AIen2026-08-15T18:36:58-07:00Meconium Aspiration Syndrome and Its Association With Preschool Asthma: A Comprehensive Review https://news.medxy.ai/ngs-flt3-itd-mrd-aml/Medxy AIen2026-08-15T13:57:20-07:00ELN‑DAVID technical recommendations: NGS-based FLT3‑ITD MRD testing in AML — what clinicians and labs need to know https://news.medxy.ai/ja/genetic-risk-mental-illness/Medxy AIja2026-08-15T11:57:43-07:00スウェーデン登録データが示す精神疾患の遺伝的リスク構造 https://news.medxy.ai/vi/genetic-risk-psych-disorders-sweden/Medxy AIvi2026-08-15T11:57:23-07:00Cấu trúc nguy cơ di truyền của các rối loạn tâm thần trong các cơ sở đăng ký dựa trên quần thể ở Thụy Điển https://news.medxy.ai/ja/psychotropic-prescriptions-us/Medxy AIja2026-08-15T11:56:24-07:00重症疾患後の精神作用薬処方、診断の裏付けなく行われることが多い米国成人での実態 https://news.medxy.ai/vi/prescription-psychotropic-effects/Medxy AIvi2026-08-15T11:56:06-07:00Kê đơn thuốc tác động lên tâm thần sau bệnh nặng ở người lớn Mỹ: nhiều trường hợp thiếu chẩn đoán hỗ trợ được ghi nhận https://news.medxy.ai/zh/diabetes-management-training/Medxy AIzh2026-08-15T11:55:16-07:00内科住院医师糖尿病管理能力提升：体验式与传统连续葡萄糖监测课程之比较 https://news.medxy.ai/ja/diabetes-training-comparison/Medxy AIja2026-08-15T11:55:02-07:00内科レジデントの糖尿病診療能力を高める：体験型と従来型のcontinuous glucose monitoringカリキュラムの比較 https://news.medxy.ai/vi/diabetes-care-training/Medxy AIvi2026-08-15T11:54:44-07:00Tăng cường năng lực chăm sóc đái tháo đường cho bác sĩ nội trú Nội khoa: So sánh chương trình CGM dựa trên trải nghiệm với chương trình truyền thống https://news.medxy.ai/ja/medicare-advantage-diabetes/Medxy AIja2026-08-15T11:53:18-07:00Medicare Advantageは2型糖尿病の転帰を改善できるか：費用増大のなかで臨床面と社会面の影響を検証する https://news.medxy.ai/zh/team-beam-preprocessing/Medxy AIzh2026-08-15T11:51:27-07:00TEAM 与 BEAM 预处理方案在淋巴瘤自体移植中的疗效与安全性比较：综合综述 https://news.medxy.ai/ja/team-vs-beam-review/Medxy AIja2026-08-15T11:51:12-07:00リンパ腫に対する自家移植でのTEAMとBEAM前処置の比較：安全性・有効性をめぐる包括的レビュー https://news.medxy.ai/vi/team-beam-lymphoma/Medxy AIvi2026-08-15T11:50:54-07:00TEAM hay BEAM trong phác đồ chuẩn bị ghép tự thân cho lymphoma: Tổng quan toàn diện về hiệu quả và độ an toàn https://news.medxy.ai/vi/eln-david-mrd-testing/Medxy AIvi2026-08-15T11:40:06-07:00Khuyến nghị kỹ thuật ELN‑DAVID: xét nghiệm MRD FLT3‑ITD dựa trên NGS trong AML — điều bác sĩ và phòng xét nghiệm cần biết https://news.medxy.ai/zh/flt3-itd-mrd-testing/Medxy AIzh2026-08-15T11:39:38-07:00ELN‑DAVID技术建议：AML中基于NGS的FLT3‑ITD MRD检测——临床医生与实验室必须了解的要点 https://news.medxy.ai/zh/long-term-safety-17a-hydroxyprogesterone/Medxy AIzh2026-08-15T10:19:38-07:00双胎宫内暴露17-α-羟孕酮己酸酯的长期安全性：一项14年随访研究 https://news.medxy.ai/ja/twin-pregnancy-safety/Medxy AIja2026-08-15T10:19:24-07:00双胎妊娠における出生前17-alpha-hydroxyprogesterone caproateの長期安全性：14年追跡研究 https://news.medxy.ai/vi/long-term-safety-17alpha-hydroxyprogesterone/Medxy AIvi2026-08-15T10:19:07-07:00An toàn dài hạn của 17-alpha-hydroxyprogesterone caproate trước sinh ở song thai: Nghiên cứu theo dõi 14 năm https://news.medxy.ai/long-term-safety-of-prenatal-17-alpha-hydroxyprogesterone-caproate-in-twins-a-14-year-follow-up-study/Medxy AIen2026-08-15T10:18:12-07:00Long-Term Safety of Prenatal 17-Alpha-Hydroxyprogesterone Caproate in Twins: A 14-Year Follow-Up Study https://news.medxy.ai/zh/ultrasound-assisted-labor/Medxy AIzh2026-08-15T10:17:53-07:00产时超声助力难产管理：优化产科决策的新工具 https://news.medxy.ai/vi/obstetric-decision-ultrasound/Medxy AIvi2026-08-15T10:17:15-07:00Nâng cao quyết định sản khoa: Vai trò của siêu âm trong chuyển dạ trong xử trí chuyển dạ khó https://news.medxy.ai/enhancing-obstetric-decision-making-the-role-of-intrapartum-sonography-in-managing-difficult-labor/Medxy AIen2026-08-15T10:16:17-07:00Enhancing Obstetric Decision-Making: The Role of Intrapartum Sonography in Managing Difficult Labor https://news.medxy.ai/ja/menopause-hormone-therapy-cost-benefit/Medxy AIja2026-08-15T10:15:40-07:00閉経ホルモン療法の費用対効果を読み解く――リスク・ベネフィットと経済モデルの統合評価 https://news.medxy.ai/cost-effectiveness-analysis-of-menopausal-hormone-therapy-integrating-risk-benefit-profiles-and-economic-models/Medxy AIen2026-08-15T10:14:00-07:00Cost-Effectiveness Analysis of Menopausal Hormone Therapy: Integrating Risk-Benefit Profiles and Economic Models https://news.medxy.ai/zh/swe-vcte-masld-risk/Medxy AIzh2026-08-15T10:13:41-07:00SWE 与 VCTE 在 MASLD 风险分层中的表现比较：基于 FIB-4 两步算法的研究解读 https://news.medxy.ai/ja/masld-risk-comparison/Medxy AIja2026-08-15T10:13:25-07:00MASLDリスク層別化におけるSWEとVCTEの比較：FIB-4に基づく二段階アルゴリズムからの知見 https://news.medxy.ai/comparative-effectiveness-of-shear-wave-elastography-and-vcte-in-masld-risk-stratification-insights-from-fib-4-based-two-step-algorithms/Medxy AIen2026-08-15T10:12:25-07:00Comparative Effectiveness of Shear Wave Elastography and VCTE in MASLD Risk Stratification: Insights from FIB-4-Based Two-Step Algorithms https://news.medxy.ai/cryptogenic-steatotic-liver-disease-a-lean-phenotype-linked-to-increased-liver-related-mortality/Medxy AIen2026-08-15T10:11:20-07:00Cryptogenic Steatotic Liver Disease: A Lean Phenotype Linked to Increased Liver-Related Mortality https://news.medxy.ai/zh/neurotransmitter-connectome-damage/Medxy AIzh2026-08-15T10:11:03-07:00神经递质引导的连接组破坏：揭示卒中后语言障碍的新关键 https://news.medxy.ai/ja/neurotransmitter-guided-connectome-disruption-to-poststroke-language-impairment/Medxy AIja2026-08-15T10:10:47-07:00神経伝達物質に規定されるコネクトーム障害：脳卒中後の言語障害の鍵 https://news.medxy.ai/vi/connectome-neurotransmitter-stroke/Medxy AIvi2026-08-15T10:10:30-07:00Rối loạn connectome được dẫn hướng bởi neurotransmitter: chìa khóa giải thích suy giảm ngôn ngữ sau đột quỵ https://news.medxy.ai/neurotransmitter-guided-connectome-disruption-as-a-key-to-poststroke-language-impairment/Medxy AIen2026-08-15T10:09:32-07:00Neurotransmitter-Guided Connectome Disruption as a Key to Poststroke Language Impairment https://news.medxy.ai/zh/acute-intracerebral-hemorrhage-dwi/Medxy AIzh2026-08-15T10:09:15-07:00急性脑内出血中的DWI阳性病灶：脑小血管病与预后的新认识 https://news.medxy.ai/ja/dwi-brain-hemorrhage/Medxy AIja2026-08-15T10:08:59-07:00急性脳内出血におけるDWI陽性病変：脳小血管病と予後を読み解く https://news.medxy.ai/vi/positive-dwi-brain-bleed/Medxy AIvi2026-08-15T10:08:40-07:00Tổn thương DWI dương tính trong xuất huyết não cấp: Gợi ý về bệnh lý mạch máu nhỏ não và tiên lượng https://news.medxy.ai/dwi-positive-lesions-in-acute-intracerebral-hemorrhage-insights-into-cerebral-small-vessel-disease-and-prognosis/Medxy AIen2026-08-15T10:08:00-07:00DWI-Positive Lesions in Acute Intracerebral Hemorrhage: Insights into Cerebral Small Vessel Disease and Prognosis https://news.medxy.ai/ja/plasma-biomarker-tau/Medxy AIja2026-08-15T10:07:42-07:00大脳新皮質タウ負荷を捉える血漿バイオマーカー https://news.medxy.ai/vi/tau-burden-biomarker/Medxy AIvi2026-08-15T10:07:24-07:00Dấu ấn sinh học huyết tương dự báo gánh nặng tau tân vỏ não https://news.medxy.ai/plasma-biomarkers-for-neocortical-tau-burden/Medxy AIen2026-08-15T10:06:28-07:00Plasma Biomarkers for Neocortical Tau Burden https://news.medxy.ai/zh/latin-america-thyroid-cancer/Medxy AIzh2026-08-15T10:06:09-07:00拉丁美洲低风险乳头状甲状腺癌热消融研究：多中心数据带来令人鼓舞的早期结果 https://news.medxy.ai/ja/low-risk-thyroid-cancer-therapy/Medxy AIja2026-08-15T10:05:51-07:00ラテンアメリカにおける低リスク乳頭甲状腺癌への熱焼灼療法：多施設研究が示した有望な初期成績 https://news.medxy.ai/vi/thermal-ablation-thyroid-cancer/Medxy AIvi2026-08-15T10:05:29-07:00Đốt nhiệt trong ung thư biểu mô nhú tuyến giáp nguy cơ thấp ở Mỹ Latinh: Kết quả sớm đầy hứa hẹn từ nghiên cứu đa trung tâm https://news.medxy.ai/thermal-ablation-for-low-risk-papillary-thyroid-cancer-in-latin-america-promising-early-outcomes-from-a-multicenter-study/Medxy AIen2026-08-15T10:04:02-07:00Thermal Ablation for Low-Risk Papillary Thyroid Cancer in Latin America: Promising Early Outcomes from a Multicenter Study https://news.medxy.ai/zh/arginine-availability-hyperglycemia/Medxy AIzh2026-08-15T10:03:45-07:00高血糖下精氨酸可利用性下降：A-β+酮症倾向性糖尿病的独特代谢特征与酮症酸中毒风险 https://news.medxy.ai/ja/arginine-utilization-diabetes/Medxy AIja2026-08-15T10:03:30-07:00A-β+ ケトーシス傾向糖尿病におけるアルギニン利用能低下：ケトアシドーシスリスクを規定する特異的代謝シグネチャー https://news.medxy.ai/vi/arginine-deficiency-diabetes/Medxy AIvi2026-08-15T10:03:13-07:00Giảm khả dụng arginine trong đái tháo đường nhiễm ceton dễ xuất hiện A-β+: Dấu ấn chuyển hóa đặc trưng liên quan nguy cơ nhiễm toan ceton https://news.medxy.ai/arginine-bioavailability-diabetes/Medxy AIen2026-08-15T10:02:13-07:00Diminished Arginine Bioavailability in A-β+ Ketosis-Prone Diabetes: A Distinct Metabolic Signature Underlying Ketoacidosis Risk https://news.medxy.ai/zh/subclinical-hypothyroidism-treatment/Medxy AIzh2026-08-15T10:01:54-07:00老年亚临床甲状腺功能减退症中左甲状腺素治疗与心代谢生物标志物：综合综述 https://news.medxy.ai/ja/levothyroxine-heart-metabolism/Medxy AIja2026-08-15T10:01:36-07:00高齢の潜在性甲状腺機能低下症におけるレボチロキシン治療と心代謝バイオマーカー：包括的レビュー https://news.medxy.ai/vi/levothyroxine-treatment-and-cardiometabolic-biomarkers-in-older-adults-with-subclinical-hypothyroidism/Medxy AIvi2026-08-15T10:01:16-07:00Điều trị bằng Levothyroxine và các dấu ấn sinh học tim-chuyển hóa ở người cao tuổi mắc suy giáp cận lâm sàng https://news.medxy.ai/levothyroxine-treatment-and-cardiometabolic-biomarkers-in-older-adults-with-subclinical-hypothyroidism-a-comprehensive-review/Medxy AIen2026-08-15T09:59:35-07:00Levothyroxine Treatment and Cardiometabolic Biomarkers in Older Adults with Subclinical Hypothyroidism: A Comprehensive Review https://news.medxy.ai/ja/housing-instability-diabetes/Medxy AIja2026-08-15T09:59:09-07:00住居不安定性は、コントロール不良糖尿病成人の費用関連治療中断と経済的困難に関連する https://news.medxy.ai/vi/housing-instability-diabetes-2/Medxy AIvi2026-08-15T09:58:51-07:00Bất ổn về nhà ở liên quan đến không tuân thủ điều trị do chi phí và khó khăn tài chính ở người lớn mắc đái tháo đường kiểm soát kém https://news.medxy.ai/housing-instability-linked-to-cost-related-medication-nonadherence-and-financial-hardship-in-adults-with-uncontrolled-diabetes/Medxy AIen2026-08-15T09:57:57-07:00Housing Instability Linked to Cost-Related Medication Nonadherence and Financial Hardship in Adults with Uncontrolled Diabetes https://news.medxy.ai/zh/weekly-icosa-vs-insulin-u100/Medxy AIzh2026-08-15T09:57:36-07:00每周一次IcoSema对比每日甘精胰岛素U100用于2型糖尿病：来自COMBINE 4 3b期试验及相关进展的证据 https://news.medxy.ai/ja/type-2-diabetes-treatment-2/Medxy AIja2026-08-15T09:57:12-07:002型糖尿病における週1回IcoSemaと毎日投与グラルギンU100：COMBINE 4第3b相試験のエビデンスと関連する最新知見 https://news.medxy.ai/vi/once-weekly-icosema-versus-daily-insulin-glargine-u100-in-type-2-diabetes/Medxy AIvi2026-08-15T09:56:50-07:00So sánh IcoSema dùng một lần mỗi tuần với Insulin Glargine U100 dùng hàng ngày ở bệnh nhân đái tháo đường tuýp 2: Bằng chứng từ thử nghiệm lâm sàng giai đoạn 3b COMBINE 4 và các tiến bộ liên quan https://news.medxy.ai/once-weekly-icosema-versus-daily-insulin-glargine-u100-in-type-2-diabetes-evidence-from-the-combine-4-phase-3b-trial-and-related-advances/Medxy AIen2026-08-15T09:55:12-07:00Once-weekly IcoSema versus Daily Insulin Glargine U100 in Type 2 Diabetes: Evidence from the COMBINE 4 Phase 3b Trial and Related Advances https://news.medxy.ai/zh/hf-risk-stratification/Medxy AIzh2026-08-15T09:54:55-07:00心衰房间隔分流治疗如何精准选人？RELIEVE-HF试验揭示个体化风险分层 https://news.medxy.ai/ja/atrial-shunt-risk-modeling/Medxy AIja2026-08-15T09:54:38-07:00心不全における心房間シャント治療の個別化リスクモデリング：RELIEVE-HF試験から得られた知見 https://news.medxy.ai/vi/shunt-therapy-risk-model/Medxy AIvi2026-08-15T09:54:17-07:00Mô hình hóa nguy cơ cá thể hóa trong liệu pháp shunt liên nhĩ ở suy tim: Góc nhìn từ thử nghiệm RELIEVE-HF https://news.medxy.ai/personalized-risk-modeling-of-interatrial-shunt-therapy-in-heart-failure-insights-from-the-relieve-hf-trial/Medxy AIen2026-08-15T09:53:24-07:00Personalized Risk Modeling of Interatrial Shunt Therapy in Heart Failure: Insights from the RELIEVE-HF Trial https://news.medxy.ai/zh/angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIzh2026-08-15T09:53:04-07:00伴心肌桥及非阻塞性冠状动脉病变的稳定型心绞痛患者接受外科“去顶术”的远期获益 https://news.medxy.ai/ja/surgical-unroofing-in-angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIja2026-08-15T09:52:48-07:00心筋ブリッジおよび非閉塞性冠動脈を有する狭心症患者における外科的筋束切除術の長期成績 https://news.medxy.ai/vi/benefits-of-surgical-unroofing-in-angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIvi2026-08-15T09:52:29-07:00Lợi ích dài hạn của phẫu thuật mở mái ở bệnh nhân đau thắt ngực có cầu cơ tim và động mạch vành không bị tắc nghẽn https://news.medxy.ai/long-term-benefits-of-surgical-unroofing-in-angina-patients-with-myocardial-bridge-and-non-obstructive-coronary-arteries/Medxy AIen2026-08-15T09:51:18-07:00Long-Term Benefits of Surgical Unroofing in Angina Patients with Myocardial Bridge and Non-Obstructive Coronary Arteries https://news.medxy.ai/zh/acute-effects-cannabis/Medxy AIzh2026-08-15T09:51:01-07:00吸入大麻对心脏异位搏动、运动、睡眠与血糖的急性影响：临床证据与机制认识的综合解读 https://news.medxy.ai/ja/cannabis-acute-effects/Medxy AIja2026-08-15T09:50:43-07:00大麻吸入の急性影響：心臓性期外収縮、身体活動、睡眠、血糖をめぐる臨床エビデンスと機序的知見の統合 https://news.medxy.ai/vi/acute-cannabis-effects/Medxy AIvi2026-08-15T09:50:23-07:00Tác động cấp tính của hít cannabis lên ngoại tâm thu tim, hoạt động thể lực, giấc ngủ và glucose: Tổng hợp bằng chứng lâm sàng và cơ chế https://news.medxy.ai/acute-effects-of-cannabis-inhalation-on-cardiac-ectopy-physical-activity-sleep-and-glucose-a-synthesis-of-clinical-evidence-and-mechanistic-insights/Medxy AIen2026-08-15T09:49:03-07:00Acute Effects of Cannabis Inhalation on Cardiac Ectopy, Physical Activity, Sleep, and Glucose: A Synthesis of Clinical Evidence and Mechanistic Insights https://news.medxy.ai/zh/prostate-cancer-metabolism/Medxy AIzh2026-08-15T09:48:40-07:00前列腺癌启动雄激素受体通路抑制剂后代谢紊乱：临床意义与风险 https://news.medxy.ai/ja/androgen-receptor-inhibitors/Medxy AIja2026-08-15T09:48:23-07:00前立腺癌におけるアンドロゲン受容体経路阻害薬導入後の代謝異常：臨床的意義とリスク https://news.medxy.ai/vi/metabolic-disorders-prostate-cancer/Medxy AIvi2026-08-15T09:48:00-07:00Rối loạn chuyển hóa sau khi khởi trị thuốc ức chế đường truyền tín hiệu thụ thể androgen ở ung thư tuyến tiền liệt: ý nghĩa lâm sàng và nguy cơ https://news.medxy.ai/metabolic-dysfunction-following-initiation-of-androgen-receptor-pathway-inhibitors-in-prostate-cancer-clinical-implications-and-risks/Medxy AIen2026-08-15T09:46:53-07:00Metabolic Dysfunction Following Initiation of Androgen Receptor Pathway Inhibitors in Prostate Cancer: Clinical Implications and Risks https://news.medxy.ai/early-features-multiple-endocrine-neoplasia/Medxy AIen2026-08-14T20:48:01-07:00Extra-Endocrine Features in Infancy as Early Clues to Multiple Endocrine Neoplasia Type 2B: A Case Series from Bambino Gesù Children’s Hospital https://news.medxy.ai/zh/pediatric-cardiac-arrest-decisions/Medxy AIzh2026-08-14T20:47:26-07:00儿童院外心搏骤停中复苏徒劳与终止决策：EMS机构间差异显著 https://news.medxy.ai/ja/pediatric-ems-variation/Medxy AIja2026-08-14T20:47:06-07:00小児院外心停止における蘇生中止判断の機関差――EMSのばらつきが示す臨床的課題 https://news.medxy.ai/vi/variability-in-futility-determinations-and-termination-of-resuscitation-for-pediatric-out-of-hospital-cardiac-arrest/Medxy AIvi2026-08-14T20:46:46-07:00Sự khác biệt giữa các đơn vị trong việc xác định tính vô ích và chấm dứt hồi sức đối với trẻ em bị ngừng tuần hoàn ngoài bệnh viện https://news.medxy.ai/agency-level-variability-in-futility-determinations-and-termination-of-resuscitation-for-pediatric-out-of-hospital-cardiac-arrest/Medxy AIen2026-08-14T20:45:51-07:00Agency-Level Variability in Futility Determinations and Termination of Resuscitation for Pediatric Out-of-Hospital Cardiac Arrest https://news.medxy.ai/ja/metastatic-castration-resistant-prostate-cancer/Medxy AIja2026-08-14T20:39:44-07:00転移性去勢抵抗性前立腺癌の全身治療：ASCO living guideline（2026.1.4版）の重要推奨 https://news.medxy.ai/vi/prostate-cancer-2026/Medxy AIvi2026-08-14T20:39:10-07:00Ung thư tuyến tiền liệt kháng thiến di căn: khuyến nghị then chốt từ Hướng dẫn sống ASCO về điều trị toàn thân (Phiên bản 2026.1.4) https://news.medxy.ai/zh/preterm-enteral-feeding/Medxy AIzh2026-08-14T20:39:06-07:00早产儿早期纯肠内喂养：荟萃分析评估其安全性与获益 https://news.medxy.ai/ja/early-enteral-nutrition/Medxy AIja2026-08-14T20:38:45-07:00早産児の早期完全経腸栄養：メタ解析でみる安全性と有用性 https://news.medxy.ai/zh/metastatic-castration-resistant-prostate-cancer-treatment/Medxy AIzh2026-08-14T20:38:34-07:00转移性去势抵抗性前列腺癌的全身治疗：ASCO 活指南（2026.1.4版）核心推荐 https://news.medxy.ai/vi/enteral-feeding-preterms/Medxy AIvi2026-08-14T20:38:25-07:00Nuôi ăn hoàn toàn qua đường ruột sớm ở trẻ sinh non: Đánh giá độ an toàn và lợi ích qua phân tích gộp https://news.medxy.ai/early-exclusive-enteral-feeding-in-preterm-infants-assessing-safety-and-benefits-through-meta-analysis/Medxy AIen2026-08-14T20:37:35-07:00Early Exclusive Enteral Feeding in Preterm Infants: Assessing Safety and Benefits through Meta-Analysis https://news.medxy.ai/systemic-therapy-for-metastatic-castration-resistant-prostate-cancer-key-recommendations-from-the-asco-living-guideline-version-2026-1-4/Medxy AIen2026-08-14T20:34:27-07:00Systemic Therapy for Metastatic Castration-Resistant Prostate Cancer: Key Recommendations from the ASCO Living Guideline (Version 2026.1.4) https://news.medxy.ai/zh/trastuzumab-therapy-salivary-cancer/Medxy AIzh2026-08-14T20:28:30-07:00曲妥珠单抗瑞泽替康用于晚期唾液腺癌：HER2 不同表达水平下均显示出令人期待的疗效 https://news.medxy.ai/ja/trastuzumab-rezetakan/Medxy AIja2026-08-14T20:27:18-07:00HER2発現を問わず有望な効果：進行唾液腺癌におけるトラスツズマブ レゼテカン https://news.medxy.ai/vi/trastuzumab-rezetecan-her2/Medxy AIvi2026-08-14T20:27:00-07:00Trastuzumab Rezetecan trong ung thư biểu mô tuyến nước bọt tiến triển: Hiệu quả đầy hứa hẹn ở nhiều mức biểu hiện HER2 https://news.medxy.ai/trastuzumab-rezetecan-in-advanced-salivary-gland-carcinoma-promising-efficacy-across-her2-expression-levels/Medxy AIen2026-08-14T20:26:13-07:00Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma: Promising Efficacy Across HER2 Expression Levels